AU1020201A - Human sphingosine kinase gene - Google Patents
Human sphingosine kinase geneInfo
- Publication number
- AU1020201A AU1020201A AU10202/01A AU1020201A AU1020201A AU 1020201 A AU1020201 A AU 1020201A AU 10202/01 A AU10202/01 A AU 10202/01A AU 1020201 A AU1020201 A AU 1020201A AU 1020201 A AU1020201 A AU 1020201A
- Authority
- AU
- Australia
- Prior art keywords
- kinase gene
- sphingosine kinase
- human sphingosine
- human
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108010035597 sphingosine kinase Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16230799P | 1999-10-28 | 1999-10-28 | |
US60162307 | 1999-10-28 | ||
US18052500P | 2000-02-07 | 2000-02-07 | |
US60180525 | 2000-02-07 | ||
PCT/EP2000/009498 WO2001031029A2 (en) | 1999-10-28 | 2000-10-27 | Human sphingosine kinase gene |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1020201A true AU1020201A (en) | 2001-05-08 |
Family
ID=26858638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU10202/01A Abandoned AU1020201A (en) | 1999-10-28 | 2000-10-27 | Human sphingosine kinase gene |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1228221A2 (pt) |
JP (1) | JP2003512072A (pt) |
AU (1) | AU1020201A (pt) |
BR (1) | BR0015138A (pt) |
CA (1) | CA2389127A1 (pt) |
MX (1) | MXPA02004294A (pt) |
WO (1) | WO2001031029A2 (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6423527B1 (en) | 1997-09-29 | 2002-07-23 | Children's Hospital Medical Center Of Northern California | Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
US6858427B2 (en) * | 2000-02-14 | 2005-02-22 | Genentech, Inc. | Sphingosine kinases |
AUPQ744700A0 (en) * | 2000-05-11 | 2000-06-01 | Medvet Science Pty. Ltd. | A method of treatment and agents useful for same |
JP2004500903A (ja) * | 2000-06-28 | 2004-01-15 | メドベット・サイエンス・プロプライエタリー・リミテッド | 治療的分子変種およびその使用方法 |
US6610534B2 (en) * | 2000-10-05 | 2003-08-26 | Novartis Ag | Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
US6858383B2 (en) | 2000-12-22 | 2005-02-22 | Medlyte, Inc. | Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
US7674580B2 (en) | 2002-01-17 | 2010-03-09 | Children's Hospital & Research Center At Oakland | Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
AU2003216076A1 (en) * | 2002-01-17 | 2003-09-02 | Children's Hospital And Research Center At Oakland | Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
US9217749B2 (en) | 2006-05-31 | 2015-12-22 | Lpath, Inc. | Immune-derived moieties reactive against lysophosphatidic acid |
US9274129B2 (en) | 2006-05-31 | 2016-03-01 | Lpath, Inc. | Methods and reagents for detecting bioactive lipids |
US9274130B2 (en) | 2006-05-31 | 2016-03-01 | Lpath, Inc. | Prevention and treatment of pain using antibodies to lysophosphatidic acid |
AU2007329759B2 (en) | 2006-10-27 | 2013-05-30 | Lpath, Inc. | Compositions and methods for binding sphingosine-1-phosphate |
US8871202B2 (en) | 2008-10-24 | 2014-10-28 | Lpath, Inc. | Prevention and treatment of pain using antibodies to sphingosine-1-phosphate |
CN109355269B (zh) * | 2018-10-21 | 2020-03-24 | 北京双因生物科技有限公司 | 鞘氨醇激酶1及其融合蛋白及其用途 |
CN113295793B (zh) * | 2021-05-20 | 2022-11-04 | 复旦大学附属中山医院 | 预测早期糖尿病以及糖尿病发生的生物标志物、其检测方法与应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998054963A2 (en) * | 1997-06-06 | 1998-12-10 | Human Genome Sciences, Inc. | 207 human secreted proteins |
AU4097999A (en) * | 1998-05-26 | 1999-12-13 | Sarah Spiegel | Sphingosine kinase, cloning, expression and methods of use |
WO2000052173A2 (en) * | 1999-03-02 | 2000-09-08 | Nps Allelix Corp. | Cloned human sphingosine kinase homologues |
JP2002538827A (ja) * | 1999-03-18 | 2002-11-19 | インサイト・ファーマスーティカルズ・インコーポレイテッド | 細胞内リン酸化反応のレギュレータ |
DE60027295T2 (de) * | 1999-05-13 | 2007-01-18 | Johnson & Johnson Pharmaceutical Research & Development, Llc | Sphingosinekinase |
-
2000
- 2000-10-27 WO PCT/EP2000/009498 patent/WO2001031029A2/en not_active Application Discontinuation
- 2000-10-27 CA CA002389127A patent/CA2389127A1/en not_active Abandoned
- 2000-10-27 MX MXPA02004294A patent/MXPA02004294A/es unknown
- 2000-10-27 EP EP00971299A patent/EP1228221A2/en not_active Withdrawn
- 2000-10-27 BR BR0015138-6A patent/BR0015138A/pt not_active IP Right Cessation
- 2000-10-27 JP JP2001533164A patent/JP2003512072A/ja active Pending
- 2000-10-27 AU AU10202/01A patent/AU1020201A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2003512072A (ja) | 2003-04-02 |
EP1228221A2 (en) | 2002-08-07 |
WO2001031029A2 (en) | 2001-05-03 |
MXPA02004294A (es) | 2002-10-31 |
CA2389127A1 (en) | 2001-05-03 |
WO2001031029A3 (en) | 2002-02-28 |
BR0015138A (pt) | 2002-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU8001600A (en) | Pillow | |
AU5173400A (en) | Protein kinases | |
AU2492000A (en) | Implantable neuro-stimulator | |
AU1101699A (en) | Therapeutic pillow | |
AU4439701A (en) | Patient support | |
EP1077996A4 (en) | GENE EDG3sb HUMAN | |
AU1020201A (en) | Human sphingosine kinase gene | |
AU2001268525A1 (en) | Human kinases | |
AU2899900A (en) | Cloned human sphingosine kinase homologues | |
AU2187301A (en) | Protein kinase regulation | |
AU2001288612A1 (en) | Human kinases | |
AU2001238488A1 (en) | Human kinases | |
AU2001277959A1 (en) | Human kinases | |
AU2292301A (en) | Human kinases | |
AUPQ262599A0 (en) | Gene expression | |
AU1548101A (en) | Sphingosine derivatives | |
EP1144628A3 (en) | Human vanilloid receptor gene | |
HUP0105208A3 (en) | Gene therapy-1 | |
AU1466401A (en) | Human transferase molecules | |
IL146332A0 (en) | PrP-LIKE GENE | |
AU2732000A (en) | Reverse gene therapy | |
AU2001255573A1 (en) | Human kinases | |
AU2002227352A1 (en) | Human kinases | |
GB9924981D0 (en) | Gene therapy | |
AU4456800A (en) | Human hac3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
TH | Corrigenda |
Free format text: IN VOL 15, NO 34, PAGE(S) 7254-7258 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 75498/00, 77764/00, 77843/00, 10202/01, 10344/01, 10348/01, 10394/01, 10443/01, 10446/01, 10511/01, 11543/01, 11551/01, 12831/01, 12838/01, 12847/01, 12862/01, 13880/01, 15598/01 AND 21565/01 |
|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |